- ykdexportsimports@gmail.Com
- +91 97 05 44 56 56
Pharmaceuticals
Pharmaceutical Products
India’s Pharmaceutical Industry, Famously Known As The “Pharmacy Of The World,” Is On Track To Reach A Valuation Of $130 Billion By 2030. Currently The Third-Largest Producer By Volume Globally, India Supplies 20% Of The World’s Generic Medicines And Approximately 60% Of Global Vaccines.
Key Strengths Of India’s Pharma Export
Scale And Volume: Home To Over 3,000 Pharmaceutical Companies And 10,500 Manufacturing Units.
Regulatory Compliance: India Has The Highest Number Of Usfda-Compliant Plants (800+) Outside The United States, Along With Numerous Facilities Approved By The Ema (Eu), Mhra (Uk), And Tga (Australia).
Cost Efficiency: Manufacturing Costs In India Are Approximately 33% Lower Than In The Us And Europe, Enabling The Production Of High-Quality Yet Affordable Medicines.
Diverse Portfolio: Key Export Categories Include Generic Formulations (79.26% Share), Active Pharmaceutical Ingredients (Apis) (16.08%), Vaccines, Biosimilars, And Ayush Products.
Major Export Destinations (2025-26)
The United States Remains The Largest Single Market, Accounting For Roughly 34% Of Total Exports.
Regulated Markets: Usa, Uk, Netherlands, Germany, And France.
Emerging Markets: South Africa, Brazil, Nigeria, Russia, Vietnam, And Mexico.